ArticleCells2022

AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys.

Mélanie Bourque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.